Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Caroline, Tournoux"'
Publikováno v:
Santé Publique. 28:481-486
Grâce a la collaboration de l’ensemble des medecins coordinateurs charges du depistage en France, les auteurs ont etudie des facteurs relatifs a l’histoire personnelle, les caracteristiques des mammographies precedant le diagnostic et des tumeur
Publikováno v:
Drug Designing: Open Access.
Background: Phase III trials can fail, leading to termination of drug development. This can result from heterogeneous subpopulations such as a drug-sensitive and a drug-insensitive subpopulation of patients or biological subtypes. Methods: Traditiona
Autor:
Anne-Sophie Rigaud, Marie Thibaud, Caroline Tournoux-Facon, Benoit Dugué, Frédéric Bloch, G. Kemoun, Cyril Breque
Publikováno v:
Geriatrics & Gerontology International. 13:250-263
The objective of this study was to analyze whether a meta-analysis could allow us to draw useful conclusions about the risk factors for falls in the elderly. A systematic review was carried out of various databases and completed manually. To satisfy
Autor:
Caroline Tournoux-Facon, Jaafar Bennouna, Jean Marc Tourani, Marie Claire Pinel, Jean Christophe Pouget, Stéphanie Favrel, Hélène Senellart, Etienne Lemarié
Publikováno v:
Journal of Thoracic Oncology. 6:1247-1253
Introduction Vinflunine (Javlor) has shown significant antitumour activity in advanced non-small cell lung cancer (NSCLC). We propose to define the recommended dose of vinflunine in combination with gemcitabine for treatment of advanced NSCLC in chem
Publikováno v:
Statistics in Medicine. 30:1555-1562
Phase II clinical trials in oncology are used for initial evaluation of the therapeutic efficacy of a new treatment regimen. Simon's two-stage or Fleming designs are commonly used for such trials. Treatment effect dilution may be observed because of
Publikováno v:
Statistics in Medicine. 30:801-811
The primary goal of phase II studies is to assess the efficacy of the new treatment in order to decide whether it has sufficient activity to warrant further evaluation in a phase III comparative trial. However, many adequately conducted phase II tria
Publikováno v:
La Presse Médicale. 38:591-596
Points essentiels • La medecine fondee sur le niveau de preuve (Evidence-based medicine) est nee dans les annees 1980. Elle a pour corollaire de s’appuyer sur une lecture critique des resultats publies. • La declaration « CONSORT » est un out
Publikováno v:
Clinical Orthopaedics & Related Research. 458:180-187
From individual randomized studies, it is unclear whether patellar tendon grafts or hamstring tendon grafts yield the best functional results after ACL reconstruction. Therefore, we performed a meta-analysis to provide quantitative data to compare pa
Publikováno v:
Cancer. 106:258-270
Participation in clinical trials remains low and is a central issue in oncology. The authors identified, through a systematic review, 75 papers published up to August 2004 that report barriers to recruitment of patients in clinical trials. These barr
Autor:
Maxime Dougados, Christian Roux, Joël Damiano, Raphaël Porcher, Sami Kolta, Caroline Tournoux
Publikováno v:
Journal of Clinical Densitometry. 9:66-71
Vertebral fractures are independent risk factors for both vertebral and peripheral fractures and only one-third of these fractures come to clinical attention. Vertebral fracture assessment (VFA) is a radiographic method using dual X-ray absorptiometr